Tevogen 1 article

Cellular medicines are central to Tevogen, an allogeneic cytotoxic T-cell company developing virus-specific off-the-shelf cellular immunotherapies. Its platform is defined by allogeneic cytotoxic T-cell immunotherapy and ExacTcell T-cell platform, while genetically unmodified CD8 T cells clarifies the relevant cell source, engineering strategy or disease application. The broader entity profile also retains high-risk viral infection immunotherapy as a secondary marker for Tevogen.